Description
An inhibitor of GSK3 (34% inhibition when used at a concentration of 2.5 µM); inhibits androgen receptor transactivation and translocation to the nucleus in PCa prostate cancer cells; increases nuclear export of the androgen receptor in PC3 prostate cancer cells; dose-dependently potentiates peak current densities